Also, additional studies including normal weight subjects with an OSA diagnosis are of great importance in order to accurately determine whether IL-10 may be useful as a marker of increased risk for OSA and insulin resistance, even in the absence of obesity. This evidence concerns the gene IL10 and obesity due to melanocortin 4 receptor deficiency.